CERC - Key Persons
Endocrinologist Aaron Hsueh discovers obestatin, a hormone that supresses appetite and may lead to treatments for obesity.
As the Financial Specialist, Amy Chen handles the financial management for the Center, enabling the attainment of More
Pharmacologist Avram Goldstein discovers a chemical in the human brain that could lead to the development of powerful painkillers with fewer undesirable side effects.
Job Titles:
- Administrative Coordinator & Program Assistant, MCiM
Bell joined the CERC team in November 2022 as a Program Assistant for the Master of Science in Clinical Informaticss Management (MCiM) program. More She has recently transitioned into the role of Administrative Coordinator to Dr. Kevin Schulman as well as continuing her role in assisting the MCiM program by supporting the program's events and calendar management.
Bell received her Bachelors of Arts degree in Humanities and Communication from CSU Monterey Bay. She also recently received her Master of Arts degree in Chicana and Chicano Studies with an emphasis in comparative Ethnic Studies from San Jose State University.
Job Titles:
- CARL and ELIZABETH NAUMANN DEAN of the SCHOOL of MEDICINE / VICE PRESIDENT for MEDICAL AFFAIRS, STANFORD UNIVERSITY
Job Titles:
- PRESIDENT & CEO / STANFORD HEALTH CARE
Job Titles:
- Dean
- Physician
- Scientist
- Surgeon
- Carl and Elizabeth Naumann Dean of the School of Medicine
- CARL and ELIZABETH NAUMANN DEAN of the SCHOOL of MEDICINE / VICE PRESIDENT for MEDICAL AFFAIRS, STANFORD UNIVERSITY
- Vice Dean Linda M. Boxer
Dean Minor is a leading physician, basic scientist and educator.
Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology-Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.
As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, "Discovering Precision Health," describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond - a multi-decade journey enabled by Precision Health.
In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.
Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology-Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital.
With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.
In 2012, Dr. Minor was elected to the National Academy of Medicine.
Carl and Elizabeth Naumann Dean of the School of Medicine,
Vice President for Medical Affairs, Stanford University,
Professor of Otolaryngology - Head and Neck Surgery, and Professor of Neurobiology and of Bioengineering, by courtesy
Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor is also a professor of Otolaryngology-Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.
As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford School of Medicine, Stanford Health Care, and Stanford Medicine Children's Health. He oversees the quality of Stanford Medicine's physicians on the faculty and in the organization's growing clinical networks and physician practices. In August 2023, Dr. Minor was appointed as Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University.
Dr. Minor has demonstrated a steadfast commitment to diversity, equity, and inclusion. For example, between 2012 and 2022, the number of underrepresented students increased from 9.9 percent of incoming PhDs to 24.6 percent and from 14 percent of incoming MDs to 28.9 percent. Other key accomplishments include quadrupling the number of women department chairs and maintaining the highest NIH funding per faculty ratio in the country.
With Dr. Minor's leadership, Stanford Medicine is leading the biomedical revolution through Precision Health. Empowering people to lead healthy lives, Precision Health is a fundamental shift to more proactive and personalized health care that predicts and prevents disease before it strikes - and cures it decisively if it does. His book, "Discovering Precision Health: Predict, Prevent, and Cure to Advance Health and Well-Being," highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases.
Dr. Minor also spearheaded the creation of an Integrated Strategic Plan (ISP) that reaffirms Stanford Medicine's Precision Health vision. A groundbreaking roadmap launched in 2018, the ISP aligns Stanford Medicine's three entities, informs how each will develop strategies, and has activated dozens of high-impact initiatives across Stanford Medicine. In 2023, Dr. Minor and the CEOs of Stanford Health Care and Stanford Medicine Children's Health launched the ISP Refresh, an initiative focused on Stanford Medicine's evolution as it leads a biomedical landscape that has rapidly evolved due to COVID-19 and other developments.
At the beginning of the COVID-19 pandemic, Dr. Minor quickly implemented protocols to ensure the safety of patients and of the Stanford Medicine community. He emphasized open communication, transparency, and accountability as he and the leadership team responded to the unprecedented challenges that affected every facet of the enterprise's activities. Under his leadership, Stanford Medicine became one of the first academic medical centers to develop a COVID-19 test, launched hundreds of clinical research projects, and distributed 480,000 vaccine doses.
In 2021, Dr. Minor articulated and began realizing a bold vision for transforming the future of life sciences at Stanford University, in the Bay Area, and beyond. This multi-decade journey will leverage the region's unique strengths in information sciences, technology, and biology and biomedicine to establish a biomedical innovation hub that, through collaboration, enhances fundamental understanding of biology and translates promising discoveries into transformative leaps that promote human and planetary well-being.
Dr. Minor has long provided significant support for basic science research and for clinical and translational research at Stanford. Through bold initiatives in medical education and increased support for MD and PhD students, Dr. Minor is committed to inspiring and training future leaders. He also has increased student financial aid and expanded faculty leadership opportunities.
Among other accomplishments, Dr. Minor has led the development and implementation of an innovative model for cancer research and patient care delivery at Stanford Medicine and has launched an initiative in biomedical data science to harness the power of big data and create a learning health care system.
Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of The Johns Hopkins University. As provost, Dr. Minor launched many university-wide initiatives such as the Gateway Sciences Initiative to support pedagogical innovation, and the Doctor of Philosophy Board to promote excellence in PhD education. He worked with others around the university and health system to coordinate the Individualized Health Initiative, which aimed to use genetic information to transform health care.
Prior to his appointment as provost in 2009, Dr. Minor was the Andelot Professor and director (chair) of the Department of Otolaryngology-Head and Neck Surgery in The Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital. During his six-year tenure, he expanded annual research funding by more than half and increased clinical activity by more than 30 percent, while strengthening teaching efforts and student training.
With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders. Through neurophysiological investigations of eye movements and neuronal pathways, his work has identified adaptive mechanisms responsible for compensation to vestibular injury in a model system for studies of motor learning (the vestibulo-ocular reflex). The synergies between this basic research and clinical studies have led to improved methods for the diagnosis and treatment of balance disorders. In recognition of his work in refining a treatment for Ménière's disease, Dr. Minor received the Prosper Ménière Society's gold medal in 2010.
In the medical community, Dr. Minor is perhaps best known for his discovery of superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. In 1998, Dr. Minor and colleagues published a description of the clinical manifestations of the syndrome and related its cause to an opening (dehiscence) in the bone covering the superior canal. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.
Dr. Minor received his bachelor's and medical degrees from Brown University. He trained at Duke University Medical Center and the University of Chicago Medical Center and completed a research fellowship at the University of Chicago and a clinical fellowship at The Otology Group and The EAR Foundation in Nashville, Tennessee.
In 2012, Dr. Minor was elected to the National Academy of Medicine.
As part of the Stanford Executive Briefing series, Minor shares his thoughts on authentic leadership and offers five leadership principles.
Sleep researcher Emmanuel Mignot identifies the defective gene that causes narcolepsy, a disabling sleep disorder affecting humans and animals.
Pathologist Eugene Butcher discovers a receptor that guides white blood cells into the peripheral lymph nodes.
Pathologist Gerald Crabtree develops techniques that allow scientists to toggle genes on and off in animal models.
Heather joined the CERC team in 2021 and provides administrative support to Dr. Arnie Milstein. Prior to CERC, More Heather worked in management consulting in San Francisco for 14+ years, after moving to the Bay Area from Hawaii in 2000. When Heather is not working with the CERC team, she spends her free time chasing after her dogs and relaxing under forest canopies.
Immunologist Hugh McDevitt discovers regulatory genes believed to control the body's reponses to foreign proteins, which suggests that people may have predictable susceptibility to certain diseases.
Pathologist Irving Weissman isolates a rare mouse cell, known as the hematopoetic stem cell, which gives rise to all the cells of the blood and immune systems.
Pathologist Irving Weissman identifies the stem cell that gives rise to bladder cancer, and also shows how the cell uses the "don't-eat-me" signal, a molecule known as CD47, to evade the body's defenses.
Pathologist Irving Weissman shows that a single antibody, which counters the effect of the CD47 molecule, shrinks a variety of human tumors transplanted into mice.
Job Titles:
- Senior Director of Operations
As the Senior Director of Operations, Jennifer Scott manages the administrative staff overseeing operations for the Center More including, strategic planning, program development, financial management, and human resource management to ensure business standards and objectives are met. Prior to CERC, Jennifer was with the University of Washington School of Dentistry RIDE program, focused on training dentists for practice in rural and underserved communities throughout the Pacific Northwest. She also has extensive management experience as the Director of Merchandising for Starbucks Coffee Company. Jennifer received her Bachelor of Arts degree in Social Welfare/Psychology with an emphasis in Public Health from the University of California Berkeley.
Job Titles:
- Peter Wood Lead the First Large Clinical Investigation That Shows Lowering Cholesterol Levels Prevents Heart Disease
John Farquhar and Peter Wood lead the first large clinical investigation that shows lowering cholesterol levels prevents heart disease.
Job Titles:
- Communications Manager
- Writer and Editor
Laurie Flynn is a writer and editor who writes about CERC research and activities. A former tech journalist, More
Laurie held various editorial positions at newspapers, online publications, and specialty magazines, covering the rise of the dot com era for The New York Times, nytimes.com, and the San Jose Mercury News. Though a Californian at heart, Laurie recently spent several years in Savannah, Georgia, where she worked as a consultant to nonfiction book authors, taught adult ed, and learned to shrimp. Her favorite editorial collaboration is a forthcoming book about the health impact of loneliness. Laurie lives with her family in San Rafael, Ca., and writes about California politics and culture for Alta Magazine.
Job Titles:
- Education Program Specialist, MCiM
Lisa became a member of the CERC team in June 2021, where she has been actively engaged with the Master of Science in Clinical More
Informatics Management (MCiM) program. She initially started as an Administrative Associate to Dr. Kevin Schulman and served as the Education Program Coordinator for the program. Recently, she transitioned into the role of Education Program Specialist.
Prior to joining CERC, Lisa has worked in Clinical IT, Health Information Management, Case Management and Clinical Social Work within The Oregon Clinic and Lucile Packard Children's Hospital at Stanford. Lisa received her Bachelor of Science degree in Child and Family Studies from Louisiana State University.
Job Titles:
- Senior Manager of Quantitative Analysis
Dr. Meg Nikolov joined CERC in July 2022 as Senior Manager of Quantitative Analysis. Prior to CERC, Meg led the Technical Consulting and Advanced More Analytics team, National Market Research at Kaiser Permanente, where her work focused on access to care, in general and for mental health in particular, and on telehealth during the COVID-19 pandemic.
Prior to relocating to the West Coast, Meg was Assistant Professor in the Math Department at the United States Naval Academy. At the Naval Academy, Meg coordinated and taught the statistics and probability courses, co-taught the capstone research course in quantitative economics, advised student research projects, and collaborated with faculty on interdisciplinary research. Meg continues to collaborate on research exploring gender and racial bias in professional performance evaluations.
Meg received her Bachelor of Science in Statistics and Biometry from Cornell University and her PhD in Biostatistics from Harvard T.H. Chan School of Public Health.
Pathologist Marius Wernig turns mouse skin cells into cells that insulate neurons with the application of just three genes.
Immunologist Mark Davis characterizes the T-cell receptor, believed to regulate the body's response to infectious agents and cancerous diseases.
Mary Gohlke receives the world's first combined heart and lung transplant in a landmark operation led by surgeon Bruce Reitz.
Job Titles:
- Executive Assistant to Dean Lloyd Minor, MD, Office of the Dean, Chief of Staff
Job Titles:
- Peter Wood Lead the First Large Clinical Investigation That Shows Lowering Cholesterol Levels Prevents Heart Disease
Surgeon Roy Cohn leads the first human kidney transplant operation on the West Coast.
Radiologist Sanjiv Gambhir develops a new type of imaging system that can illuminate tumors in living subjects with a precision of nearly one-trillionth of a meter
Sujin joined the CERC team in August 2023 as a Research Data Analyst. She supports and reports to Dr. Meg Nikolov. More
Prior to CERC, Sujin was a Data Analyst at a healthcare management company. She worked with clients in the healthcare sector, and she performed data wrangling and migration to successfully transfer client data into a new system.
Sujin received her Bachelor of Science degree in Statistics from the University of California, Davis.
Susan joined the CERC team in October 2016 as the team's Administrative Associate to support Dr. Arnold Milstein. She now plays a critical More role by providing operational support to CERC management and special projects. She ensures administrative functions run smoothly and transparently. Susan received her Bachelor of Arts degree from the University of California at Santa Barbara.
Job Titles:
- Associate Director of Admissions & Administration, MCiM
Tatiana joined the CERC team in November 2022 as the Associate Director of Admissions & Administration for the Master of Science More
Pediatrician Thomas Robinson finds that children who curtailed their television time gained significantly less body fat than those who didn't .
Job Titles:
- Research Operations Manager
Tracy is a 15+ year administrative veteran for the Stanford School of Medicine. More She started at the Lane Medical Library and is currently with the Clinical Excellence Research Center.
Job Titles:
- Operations and Student Services Manager, MCiM
Veronica joined the CERC team in September 2018 as an Administrative Associate to Drs. Kevin Schulman and More
Researcher William Haskell shows that intensive lifestyle changes and prevention/treatment programs can reduce cardiac events and slow the progression of atherosclerosis in coronary arteries.
Researcher William S. Robinson isolates the genetic blueprint of a virus that causes hepatitis B and a common form of liver cancer.